Pictures from the main event 2020 on life sciences in the next decade
-
Dec. 15, 2020Welcome: Visions for life science research, education and innovation at UiO and the importance of the new life science building that is ready for use in 2024
Svein St?len, PhD
Rector, UiO
-
Dec. 15, 2020Our chair for the main event was science journalist Hanne ?stli Jakobsen
-
Dec. 15, 2020Value creation through digitalisation and AI in life sciences – how to utilise Norwegian advantages
Paul Chaffey, State Secretary to the Minister of Regional Development and Digitalisation (Conservative Party)
-
Dec. 15, 2020How to use AI to improve patient care and accelerating medical research
Rabia Khan, PhD?MBA
Chief of Translational Medicine, Sensyne Health, UK
-
Dec. 15, 2020Faster and safer cancer prognostics with AI
H?vard E. Danielsen, PhD
Professor, Department of Informatics, UiO; Director, Institute for Cancer Genetics and Informatics, Oslo University Hospital; and PI in the DoMore! project
-
Dec. 15, 2020Improving AI with cutting edge brain research – an interdisciplinary approach
Marianne Fyhn, PhD
Professor, Department of Biosciences, UiO; leader of Centre for Integrative Neuroplasticity (CINPLA); and member of the UiO:Life Science convergence environment MultiModal Mental Models (4MENT)
-
Dec. 15, 2020The ERC in EU Framework Programmes: bringing value from bottom-up research in life sciences
Philippe Cupers, PhD
Head of the Life Sciences unit (ERCEA.B.3), European Research Council (ERC) Executive Agency
-
Dec. 15, 2020New opportunities for collaboration between big pharma and academia in White City Campus in London – a role model for Oslo Science City?
Mark Toms, Dr.
Medical Director & Chief Scientific Officer, Novartis UK
-
Dec. 15, 2020The need for innovation in health care – success stories and success factors and opportunities at BII also for Oslo-based researchers and entrepreneurs
Herv?r Lykke Olsen, PhD
Senior business developer, BioInnovation Institute (BII), Denmark
-
Dec. 15, 2020New trends in innovation and collaboration in health-related and environmental life sciences – why are Nordic actors attractive partners for Fraunhofer?
Claus-Dieter Kroggel, PhD
Head of Central Office, Fraunhofer Group for Life Sciences, Germany
-
Dec. 15, 2020Our chair for the pitching session was Jutta Heix from Oslo Cancer Cluster
We had pitches from UiO:Life Science's convergence environments, projects in UiO:Life Science's innovation programme for health related life sciences SPARK Norway and industry in Oslo.
-
Dec. 15, 2020Future models for diabetes research by using new strategies for stem cell differentiation – collaboration between medicine, musicology and physics
Hanne Scholz, PhD
Leader of the convergence environment Artificial Biomimetic systems – the Niche of Islet Organoids (ABINO), PI in the convergence environment Organ on a chip and Vice Director of the Centre of Excellence Hybrid Technology Hub
-
Dec. 15, 2020Inhibition of aortic valve calcification
SPARKee K?re-Olav Stensl?kken, Professor
Institute of Basic Medical Sciences, Faculty of Medicine, UiO. He is also leader a convergence environment.
-
Dec. 15, 2020MyFood – a decision support system to prevent and treat disease-related malnutrition
SPARKee Mari Mohn Paulsen, PhD student
Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, UiO
-
Dec. 15, 2020Fabuli – Faster and Better Ultrasound Imaging
SPARKee Andreas Austeng, Professor
Department of Informatics, The Faculty of Mathematics and Natural Sciences, UiO
-
Dec. 15, 2020Empowering cancer immunotherapy with AI
Jenny-Ann Malmberg, PhD
Software Development Manager, NEC Oncoimmunity
-
Dec. 15, 2020Legal aspects of AI
Vibeke Binz Vallevik
Project Manager the BIGMED Project, DNV GL Precision Medicine research and OUS Intervention Center
-
Dec. 15, 2020Conversation between Carl Henrik G?rbitz, director of UiO:Life Science, and the new UiO:Life Science Strategic Advisory Board (SAB) with Laurence D. Hurst, Professor of Evolutionary Genetics and Director of the Milner Centre for Evolution Department of Biology and Biochemistry, The University of Bath; Sirpa Jalkanen, Professor of Immunology, Academician, Director of MediCity, University of Turku, Finland and Jari Koistinaho, Director of Neuroscience Center, Helsinki Institute of Life Science, University of Helsinki and Professor of Regenerative Medicine, University of Eastern Finland.
The fourth member of the SAB, Melissa Parker, Professor of Medical Anthropology, Department of Global Health and Development, London School of Hygiene and Tropical Medicine, was not present at the event.
